Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ultra-micronized palmitoyl ethylamine (PEA) FSD-201

An orally bioavailable, ultra-micronized formulation of the fatty acid amide palmitoyl ethylamine (PEA), with potential anti-inflammatory activity. Upon oral administration, ultra-micronized PEA FSD-201 may inhibit both mast cell activation and migration, and the release of pro-inflammatory mediators from activated mast cells. This may reduce inflammation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:FSD-PEA
ultra-micronized PEA FSD-201
Code name:FSD 201
FSD-201
FSD201
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search